Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by JDavenporton Apr 06, 2022 10:36am
65 Views
Post# 34580350

RE:RE:After 14 years, GET AN IND SUBMISSION IN TO THE FDA!!

RE:RE:After 14 years, GET AN IND SUBMISSION IN TO THE FDA!!Hey, Sdpp, in reality, everything about Bioasis has always been for sale. The strategy was to never go past phase one with anything. You gotta find some earlier stuff to copy/paste.

Glossary

Sdpp: An acronym for Sir_Holler, digitel, prophetoffacts, prophetoffact

jd
<< Previous
Bullboard Posts
Next >>